Works matching IS 00070920 AND DT 2015 AND VI 112 AND IP 8

Results: 15

Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1376, doi. 10.1038/bjc.2015.97

By:

Mizuno, M;
Kajiyama, H;
Shibata, K;
Mizuno, K;
Kawai, M;
Nagasaka, T;
Kikkawa, F

Publication type:

Article

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1340, doi. 10.1038/bjc.2015.74

By:

Mahon, K L;
Lin, H-M;
Castillo, L;
Lee, B Y;
Lee-Ng, M;
Chatfield, M D;
Chiam, K;
Breit, S N;
Brown, D A;
Molloy, M P;
Marx, G M;
Pavlakis, N;
Boyer, M J;
Stockler, M R;
Daly, R J;
Henshall, S M;
Horvath, L G

Publication type:

Article

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1314, doi. 10.1038/bjc.2015.93

By:

Verstraete, M;
Debucquoy, A;
Dekervel, J;
van Pelt, J;
Verslype, C;
Devos, E;
Chiritescu, G;
Dumon, K;
D'Hoore, A;
Gevaert, O;
Sagaert, X;
Van Cutsem, E;
Haustermans, K

Publication type:

Article

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1411, doi. 10.1038/bjc.2015.80

By:

Wong, S Q;
Fellowes, A;
Doig, K;
Ellul, J;
Bosma, T J;
Irwin, D;
Vedururu, R;
Tan, A Y-C;
Weiss, J;
Chan, K S;
Lucas, M;
Thomas, D M;
Dobrovic, A;
Parisot, J P;
Fox, S B

Publication type:

Article

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1306, doi. 10.1038/bjc.2015.88

By:

Bork, U;
Rahbari, N N;
Schölch, S;
Reissfelder, C;
Kahlert, C;
Büchler, M W;
Weitz, J;
Koch, M

Publication type:

Article

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1358, doi. 10.1038/bjc.2015.20

By:

Meulendijks, D;
Tomasoa, N B;
Dewit, L;
Smits, P H M;
Bakker, R;
van Velthuysen, M-L F;
Rosenberg, E H;
Beijnen, J H;
Schellens, J H M;
Cats, A

Publication type:

Article

Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1392, doi. 10.1038/bjc.2015.75

By:

Kratz, C P;
Franke, L;
Peters, H;
Kohlschmidt, N;
Kazmierczak, B;
Finckh, U;
Bier, A;
Eichhorn, B;
Blank, C;
Kraus, C;
Kohlhase, J;
Pauli, S;
Wildhardt, G;
Kutsche, K;
Auber, B;
Christmann, A;
Bachmann, N;
Mitter, D;
Cremer, F W;
Mayer, K

Publication type:

Article

Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1398, doi. 10.1038/bjc.2015.104

By:

Matsubara, A;
Ogawa, R;
Suzuki, H;
Oda, I;
Taniguchi, H;
Kanai, Y;
Kushima, R;
Sekine, S

Publication type:

Article

Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1349, doi. 10.1038/bjc.2015.99

By:

Melchers, L J;
Mastik, M F;
Samaniego Cameron, B;
van Dijk, B A C;
de Bock, G H;
van der Laan, B F A M;
van der Vegt, B;
Speel, E J M;
Roodenburg, J L N;
Witjes, M J H;
Schuuring, E

Publication type:

Article

miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1367, doi. 10.1038/bjc.2015.102

By:

Zhu, Z;
Xu, Y;
Zhao, J;
Liu, Q;
Feng, W;
Fan, J;
Wang, P

Publication type:

Article

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1326, doi. 10.1038/bjc.2014.541

By:

Algazi, A P;
Cha, E;
Ortiz-Urda, S M;
McCalmont, T;
Bastian, B C;
Hwang, J;
Pampaloni, M H;
Behr, S;
Chong, K;
Cortez, B;
Quiroz, A;
Coakley, F;
Liu, S;
Daud, A I

Publication type:

Article

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1384, doi. 10.1038/bjc.2015.100

By:

Fisher, O M;
Levert-Mignon, A J;
Lord, S J;
Lee-Ng, K K M;
Botelho, N K;
Falkenback, D;
Thomas, M L;
Bobryshev, Y V;
Whiteman, D C;
Brown, D A;
Breit, S N;
Lord, R V

Publication type:

Article

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1405, doi. 10.1038/bjc.2015.98

By:

Fitzal, F;
Filipits, M;
Rudas, M;
Greil, R;
Dietze, O;
Samonigg, H;
Lax, S;
Herz, W;
Dubsky, P;
Bartsch, R;
Kronenwett, R;
Gnant, M

Publication type:

Article

Economic evaluation for the UK of nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreas cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1301, doi. 10.1038/bjc.2015.65

By:

Gharaibeh, M;
McBride, A;
Bootman, J L;
Abraham, I

Publication type:

Article

Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 8, p. 1332, doi. 10.1038/bjc.2015.114

By:

Sun, S;
Liang, X;
Zhang, X;
Liu, T;
Shi, Q;
Song, Y;
Jiang, Y;
Wu, H;
Lu, X;
Pang, D

Publication type:

Article